Testing whether expert team reviews help adults with cancer that spread to the brain
Original title: University of Kentucky Markey Cancer Center Neuro-Oncology Multi-Disciplinary Tumor Board Protocol for the Treatment of Advanced Brain Metastases
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
No phase is listed for this study, and it is still being tested.
Status: Not yet recruiting. It has not opened yet. Ask your care team to watch for it if it looks like a fit.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This study asks if a team of brain cancer experts reviewing your case leads to better care.
Who this trial is for. This trial is for adults with advanced cancer that has spread to the brain. It tests whether review by the Markey Cancer Center brain tumor board leads to better care, while people get standard treatment from their own doctors.
Where it stands. The trial has not reported results. It plans to look at how long people live, how long before the cancer grows, and which treatment is chosen. It also compares people who follow the team's advice with those who do not.
What this means, and what it doesn't
What it could mean: If this sounds like your situation, you could ask your care team about it. Over time, the study may show whether team reviews lead to better care.
What it doesn't mean: This does not mean the team review is proven to help. A trial is a test, not a proven treatment. Being in one is not a guarantee that you will do better. It is not a promise of a cure.
Source: ClinicalTrials.gov, August 25, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.